Helping Pharmacists Respond to the H1N1 Flu Outbreak

The recent outbreak of H1N1 Influenza has taken the globe by storm and is predicted by the CDC to continue to spread. As front line health care professionals, pharmacists need the most up-to-date information to answer questions on the infection and how to stop its spread and education of patients and the healthcare community on the appropriate use of antivirals.

Vaccines for H1N1 Flu

• Influenza A (H1N1) 2009 Vaccine Inactivated (AHFS full-length) [PDF]
• Influenza A (H1N1) 2009 Vaccine Inactivated (abbreviated essential) [PDF]

• Influenza A (H1N1) 2009 Vaccine Live Intranasal (AHFS full-length) [PDF]
• Influenza A (H1N1) 2009 Vaccine Live Intranasal (abbreviated essential) [PDF]

• Letter from the Commissioner to Nation's Healthcare Professionals on H1N1 Vaccine (FDA)
• H1N1 Vaccination Recommendations (ACIP)
• H1N1 Vaccine Safety Monitoring
• Medicare Fee-for-Service Information on H1N1 Vaccine [PDF]

News on H1N1 Vaccine Use and Supplies

• (H1N1) Influenza Vaccine in Pre-Filled Syringes - Shortened Shelf Life of Certain Lots [PDF]
• AJHP Editorial: Health Care Workers and Influenza Vaccination [PDF]
  Originally published in Am J Health Syst Pharm - Vol 67 (1): 25. © 2010, American Society of Health-System Pharmacists, Inc. All rights reserved. Posted with permission.
• Non-Safety Related Voluntary Recall of Certain Lots of Sanofi Pasteur H1N1 Pediatric Vaccine (CDC)
• 2009 H1N1 Influenza Vaccine Supply Status (CDC)
• One H1N1 Vaccine Dose Should Offer Protection in Most Children
• FDA Approves the 2009 H1N1 Vaccines from Four Manufacturers
• CDC's Influenza Vaccination Record Cards Now Available [PDF]
• Report to the President on U.S. Preparations for 2009 H1N1 Influenza [PDF]
• H1N1 Vaccination Campaign Could be Largest in Human History (Washington Post)

Antivirals for H1N1 Flu

Peramivir IV (Unapproved)

• Peramivir IV Renal Dosing Recommendations (FDA)
• Emergency-use authorization of peramivir [PDF]
• Emergency Use Authorization of Peramivir IV: Fact Sheet for Health Care Providers [PDF]

Oseltamivir Drug Information

• Healthcare Professional (AHFS full-length) [PDF]
• Healthcare Professional (abbreviated essential) [PDF]
• Patient Information
• Instructions for oseltamivir suspension (see page 19, prescribing information)

• Healthcare Professional (AHFS full-length) [PDF]
• Healthcare Professional (abbreviated essential) [PDF]
• Patient Information

• Interim Guidance on Antiviral Recommendations
• Guidance for specific populations (e.g. pregnant and breastfeeding women) (CDC)
• Antiviral Treatment Options, including Intravenous Peramivir, for Treatment of Influenza in Hospitalized Patients for the 2009-2010 Season

News on Antiviral Use and Supplies

• Guidance to Pharmacies on Advance Compounding of Tamiflu Oral Suspension to Provide for Multiple Prescriptions
• Potential Medication Errors with Tamiflu for Oral Suspension (FDA)
• Stockpiled Antivirals at or Nearing Expiration (FDA)
• Action Taken to Prevent Hoarding of Flu Drugs (New York Times)
• Swine flu: Careful Use of antivirals needed now (Chicago Tribune)
• Use antiviral drugs carefully, health officials warn (Los Angeles Times)

Pandemic Flu Planning

• Pharmacy in Public Health: Basics and Beyond (see Chapter 14: A Community Pharmacy Influenza Vaccination Service)
• Webinar Planning in a Pandemic The Looming H1N1 Crisis and What it Means for You...
  • Handout [PPT]
• ASHP Foundation Comprehensive Planning Resources
• Medical Offices and Clinics Pandemic Influenza Planning [PDF]
• Federal Response Stages for Pandemic Flu [PDF]
• State Pandemic Plans
• AHRQ Pandemic Preparedness Resources
• Institute of Medicine Pandemic Influenza Resources